Renaissance Technologies LLC 13D and 13G filings for Aclaris Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-10 2:17 pm Sale |
2021-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
Renaissance Technologies LLC | 1,676,878 2.740% |
-1,591,300 (-48.69%) |
Filing |
| 2021-02-10 8:48 pm Purchase |
2020-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
Renaissance Technologies LLC | 3,268,178 7.610% |
485,881 (+17.46%) |
Filing |